Pancreatic Cancer Research

ResearcherStanford MedicineActive in the last 2 years

Brendan Christopher Visser

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4874-1874; OpenAlex author ID A5081036941. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 10

  1. NFAT mediates pro-tumorigenic inflammation in cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2025.116849↗
  2. Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best? Co-author DOI 10.1097/sla.0000000000006609↗
  3. Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2025.116347↗
  4. Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes. Co-author DOI 10.1245/s10434-023-13120-3↗
  5. Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System. Co-author DOI 10.1097/mpa.0000000000001314↗
  6. Management of Borderline Resectable Pancreatic Cancer. Co-author DOI 10.1016/j.ijrobp.2017.12.287↗
  7. Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000470↗
  8. Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. Co-author DOI 10.1016/j.ijrobp.2014.06.066↗
  9. Intensity-modulated radiotherapy for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ijrobp.2011.09.035↗
  10. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. Co-author DOI 10.1111/j.1477-2574.2012.00496.x↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. George A. Poultsides · 10 shared papers, 2012–2026 · strength 1.14
  2. Jeffrey Allen Norton · 7 shared papers, 2012–2026 · strength 0.79
  3. Daniel Tandel Chang · 7 shared papers, 2012–2026 · strength 0.71
  4. Daniel Delitto · 3 shared papers, 2025–2026 · strength 0.63
  5. George Albert Fisher · 5 shared papers, 2012–2026 · strength 0.56
  6. Erqi Liu Pollom · 4 shared papers, 2014–2026 · strength 0.54
  7. Albert C. Koong · 6 shared papers, 2012–2023 · strength 0.47
  8. Byrne Lee · 2 shared papers, 2025–2026 · strength 0.42
  9. Amanda Kirane · 2 shared papers, 2025–2026 · strength 0.42
  10. Maria Moozhiyil Korah · 2 shared papers, 2025–2026 · strength 0.39
  11. James Paul Agolia · 2 shared papers, 2025–2026 · strength 0.39
  12. Deshka S. Foster · 2 shared papers, 2025–2026 · strength 0.39
  13. Jason L. Guo · 2 shared papers, 2025–2026 · strength 0.39
  14. Michael Thornton Longaker · 2 shared papers, 2025–2026 · strength 0.39
  15. Chuner Guo · 2 shared papers, 2025–2026 · strength 0.39
  16. Diego A.S. Toesca · 3 shared papers, 2018–2023 · strength 0.34
  17. R. Brooke Jeffrey · 2 shared papers, 2019–2023 · strength 0.25
  18. M. Usman Ahmad · 1 shared paper, 2026 · strength 0.24
  19. Gregory M. Heestand · 1 shared paper, 2026 · strength 0.24
  20. Annah Grace Morgan · 1 shared paper, 2026 · strength 0.22
  21. Mary Uan-Sian Feng · 1 shared paper, 2023 · strength 0.16
  22. Amanda Jeanette Koong · 1 shared paper, 2018 · strength 0.09
  23. James M. Ford · 2 shared papers, 2012–2014 · strength 0.06
  24. Pamela L. Kunz · 2 shared papers, 2012–2014 · strength 0.06
  25. Eric M. Anderson · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.